The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Pacific Biosciences of California Inc’s current trading price is -45.40% away from its 52-week high, while its distance from the 52-week low is 74.48%. The stock’s price range for this period has been between $0.85 and $2.72 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.26 million for the day, a number notably lower than the average daily volume of 8.9 million over the last three months.
At present, Pacific Biosciences of California Inc (PACB) has a stock price of $1.49. In the previous session, the stock saw a rise, peaking at $3.0 after an opening price of $1.48. The day’s lowest price was $1.25, and it closed at $1.46.
The market performance of Pacific Biosciences of California Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $2.72 on 11/07/24, while the lowest value for the same duration was $0.85 on 05/28/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 9.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 445.62M and boasts a workforce of 575 employees.
Pacific Biosciences of California Inc: What Analysts Are Saying
As of right now, 5 analysts are rating Pacific Biosciences of California Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2402, with a change in price of -0.2895. Similarly, Pacific Biosciences of California Inc recorded 9,192,405 in trading volume during the last 100 days, posting a change of -16.36%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 7.63. Similarly, the long-term debt-to-equity ratio is also 7.60.
PACB Stock Stochastic Average
As of today, Pacific Biosciences of California Inc’s raw stochastic average for the last 50 days stands at 79.81%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 68.10%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 66.70% and 68.31%, respectively.
PACB Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -1.00%.However, over the last six months, we can see a stronger performance of -29.29%. Over the last 30 days, the price of PACB has fallen by 25.85%. And in the last five days, it has fallen by -1.00%.
